SEATTLE, Wash. — A COVID-19 vaccine developed at the University of Washington Medical Center in Seattle is looking promising.
A study showed that a single dose of the vaccine, which goes by the acronym LION, was effective against the virus in mice and non-human primates.
Researcher Deborah Fuller says it instructs cells to produce more of the beneficial RNA protein.
She says the vaccine’s components are quick to manufacture in large quantities and its design would allow it to be administered after a simple mixing step at a pharmacy.
If the vaccine meets the few next steps in its evaluation, it would enter trials in healthy human volunteers.